Page last updated: 2024-08-21

oxazoles and Tuberculosis, Pulmonary

oxazoles has been researched along with Tuberculosis, Pulmonary in 34 studies

Research

Studies (34)

TimeframeStudies, this research(%)All Research%
pre-19908 (23.53)18.7374
1990's1 (2.94)18.2507
2000's4 (11.76)29.6817
2010's16 (47.06)24.3611
2020's5 (14.71)2.80

Authors

AuthorsStudies
Bin, W; Chen, S; Ding, CZ; Franzblau, SG; Hu, Y; Huang, Z; Jiang, N; Luo, W; Shen, L; Tao, X; Wei, X; Wei, Y; Xu, D; Yang, M; Zhu, Y1
Kudoh, S; Kurashima, A; Ogata, H; Ohta, K; Okumura, M; Yoshimori, K; Yoshiyama, T1
Jeon, D; Jo, KW; Kang, H; Shim, TS; Yim, JJ1
Gibiansky, E; Mallikaarjun, S; Wang, X1
Chopra, V; Gupta, A1
Akkerman, O; Alffenaar, JW; Amale, R; Centis, R; D'Ambrosio, L; Ganatra, S; Maryandyshev, A; Migliori, GB; Mullerpattan, J; Pontali, E; Sadutshang, TD; Sotgiu, G; Tiberi, S; Topgyal, S; Udwadia, ZF1
Dowdy, D; Merritt, MW; Taylor, H; von Delft, A; Zwerling, A1
Centis, R; D'Ambrosio, L; Migliori, GB; Pontali, E; Spanevello, A; Visca, D1
Ade, S; Alikhanova, N; Benedetti, G; Cox, H; Daniels, J; De Azevedo, V; Edwards, J; Ferlazzo, G; Furin, J; Hughes, J; Isaakidis, P; Kock, Y; Mohr, E; Reuter, A; Shroufi, A; Steele, SJ; Trivino Duran, L1
Balanag, V; Bielskiene, V; Cadena, E; Caoili, J; Cirule, A; Danilovits, M; Davidaviciene, E; Domente, L; Geiter, LJ; Gupta, R; Hafkin, J; Hittel, N; Lizarbe, V; Patientia, R; Petersen, C; Sanchez, E; Segura, P; Staples, S; Ticona, E; Variava, E; von Groote-Bidlingmaier, F; Wells, C; Yu, C1
Ahn, H; Ahn, JH; Cho, SN; Hahn, S; Jang, JY; Jeon, D; Jhun, BW; Jo, KW; Kang, YA; Kim, CK; Kim, DK; Kim, JS; Kim, SY; Kim, YR; Koh, WJ; Lee, JH; Lee, JY; Lee, M; Lee, SH; Lee, T; Mok, J; Park, JS; Shim, TS; Shin, S; Shin, SJ; Song, T; Won, HJ; Yim, JJ1
Arora, VK; Chopra, KK1
Jeong, BH; Koh, WJ; Kwon, YS1
Lynch, JB; Szumowski, JD1
Bianchini, S; Blasi, F; Esposito, S1
Betoudji, F; Converse, PJ; Dartois, V; Li, SY; Mdluli, KE; Mendel, CM; Nuermberger, EL; Tasneen, R; Tyagi, S; Williams, K; Yang, T1
Dawson, A; Silva, DS; Upshur, RE1
Fujiwara, M; Geiter, L; Kawasaki, M; Kreiswirth, BN; Kurepina, N; Liu, Y; Matsumoto, M; Shashkina, E; Stinson, K; Timm, J; Venter, A1
Dass, R; Hettle, R; Wirth, D1
Mancera, RL; Rivers, EC1
Dawson, R; Diacon, AH; Donald, PR; Geiter, LJ; Hanekom, M; Hittel, N; Narunsky, K; Paccaly, AJ; Venter, A; Wells, CD1
Bandermann, S; Hahnke, K; Kahnert, A; Kaufmann, SH; Mollenkopf, H; Seiler, P; Stein, M1
Zhang, Y1
Kobayashi, K; Okada, M1
Ashtekar, DR; Bhatt, AD; Costa-Perira, R; Nagrajan, K; Rittel, W; Vishvanathan, N1
Papezhova, E; Toushek, I1
Kheifets, LB; Kozlova, NE1
Kolosovskaia, VP; Shabalova, LN; Shmelev, NA1
Kolosovskaia, VP; Korotaev, GA1
Böszörményi, M1
Aimone, J; Dumon, G; Dumon, JF1
Tousek, J; Zítková, L1
Antunes, G; Gomes, A; Rizzo, A1

Reviews

7 review(s) available for oxazoles and Tuberculosis, Pulmonary

ArticleYear
Evolution of newer regimens in TB from RNTCP to NTEP.
    The Indian journal of tuberculosis, 2020, Volume: 67, Issue:4S

    Topics: Antitubercular Agents; Diarylquinolines; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Nitroimidazoles; Oxazoles; Tuberculosis, Pulmonary

2020
Multi and extensively drug-resistant pulmonary tuberculosis: advances in diagnosis and management.
    Current opinion in pulmonary medicine, 2018, Volume: 24, Issue:3

    Topics: Adolescent; Antitubercular Agents; Child; Diarylquinolines; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Humans; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2018
Delamanid when other anti-tuberculosis-treatment regimens failed due to resistance or tolerability.
    Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:2

    Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2015
Profile of delamanid for the treatment of multidrug-resistant tuberculosis.
    Drug design, development and therapy, 2015, Volume: 9

    Topics: Animals; Antitubercular Agents; Drug Interactions; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Long QT Syndrome; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Risk Assessment; Risk Factors; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2015
Bedaquiline and delamanid in tuberculosis.
    Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:15

    Topics: Antitubercular Agents; Clinical Trials as Topic; Diarylquinolines; Drug Interactions; Drug Resistance, Bacterial; Humans; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2015
New anti-tuberculosis drugs with novel mechanisms of action.
    Current medicinal chemistry, 2008, Volume: 15, Issue:19

    Topics: Adamantane; Animals; Antitubercular Agents; Diarylquinolines; Drug Design; Drug Resistance, Multiple, Bacterial; Ethylenediamines; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Quinolines; Structure-Activity Relationship; Tuberculosis, Pulmonary

2008
Advances in the treatment of tuberculosis.
    Clinical pharmacology and therapeutics, 2007, Volume: 82, Issue:5

    Topics: Adamantane; AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Drugs, Investigational; Ethylenediamines; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Pyrazinamide; Rifampin; Treatment Refusal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2007

Trials

6 trial(s) available for oxazoles and Tuberculosis, Pulmonary

ArticleYear
Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial.
    The Lancet. Respiratory medicine, 2019, Volume: 7, Issue:3

    Topics: Antitubercular Agents; Double-Blind Method; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Nitroimidazoles; Oxazoles; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2019
Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, m
    Trials, 2019, Jan-16, Volume: 20, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Equivalence Trials as Topic; Female; Humans; Levofloxacin; Linezolid; Male; Middle Aged; Multicenter Studies as Topic; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Pyrazinamide; Republic of Korea; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult

2019
MIC of Delamanid (OPC-67683) against Mycobacterium tuberculosis Clinical Isolates and a Proposed Critical Concentration.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Tuberculosis, Pulmonary

2016
Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2011, Volume: 15, Issue:7

    Topics: Adolescent; Adult; Antitubercular Agents; Colony Count, Microbial; Dose-Response Relationship, Drug; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Sputum; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult

2011
[Comparative clinical electroencephalographic study of cycloserine and terizidon tolerance].
    Antibiotiki, 1975, Volume: 20, Issue:2

    Topics: Adolescent; Adult; Antitubercular Agents; Central Nervous System; Chronic Disease; Clinical Trials as Topic; Cycloserine; Drug Tolerance; Electroencephalography; Humans; Imines; Male; Middle Aged; Oxazoles; Tuberculosis, Pulmonary

1975
[Triple placebo test for comparison of side effects of terizidone (terivalidin) and cycloserine].
    International journal of clinical pharmacology, therapy and toxicology, 1973, Volume: 8, Issue:1

    Topics: Clinical Trials as Topic; Cycloserine; Female; Humans; Imines; Male; Mental Disorders; Oxazoles; Seizures; Sleep Initiation and Maintenance Disorders; Tremor; Tuberculosis, Pulmonary; Vertigo

1973

Other Studies

21 other study(ies) available for oxazoles and Tuberculosis, Pulmonary

ArticleYear
Discovery and preclinical evaluations of JBD0131, a novel nitrodihydro-imidazooxazole anti-tuberculosis agent.
    Bioorganic & medicinal chemistry letters, 2022, 09-15, Volume: 72

    Topics: Antitubercular Agents; Humans; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2022
Treatment of multidrug-resistant pulmonary tuberculosis with delamanid based on Japanese guideline recommendations.
    Respiratory investigation, 2020, Volume: 58, Issue:2

    Topics: Adult; Antitubercular Agents; Drug Resistance, Multiple; Female; Humans; Japan; Male; Middle Aged; Nitroimidazoles; Oxazoles; Practice Guidelines as Topic; Tuberculosis, Pulmonary

2020
Interim treatment outcomes in multidrug-resistant tuberculosis using bedaquiline and/or delamanid in South Korea.
    Respiratory medicine, 2020, Volume: 167

    Topics: Age Factors; Aged; Body Mass Index; Diarylquinolines; Drug Resistance, Bacterial; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nitroimidazoles; Oxazoles; Republic of Korea; Retrospective Studies; Risk Factors; Safety; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary

2020
Population Pharmacokinetic Analysis of Delamanid in Patients with Pulmonary Multidrug-Resistant Tuberculosis.
    Antimicrobial agents and chemotherapy, 2020, 12-16, Volume: 65, Issue:1

    Topics: Adolescent; Adult; Antitubercular Agents; Humans; Middle Aged; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult

2020
Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis.
    Emerging infectious diseases, 2017, Volume: 23, Issue:10

    Topics: Adolescent; Adult; Antitubercular Agents; Diarylquinolines; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Nitroimidazoles; Oxazoles; Tuberculosis, Pulmonary; Young Adult

2017
Incorporating social justice and stigma in cost-effectiveness analysis: drug-resistant tuberculosis treatment.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2017, 11-01, Volume: 21, Issue:11

    Topics: Antitubercular Agents; Cost-Benefit Analysis; Decision Trees; Diarylquinolines; Humans; Models, Theoretical; Nitroimidazoles; Oxazoles; Social Justice; Social Stigma; South Africa; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2017
Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa.
    The European respiratory journal, 2018, Volume: 51, Issue:6

    Topics: Adult; Antitubercular Agents; Female; Humans; Logistic Models; Male; Nitroimidazoles; Oxazoles; Retrospective Studies; Rifampin; South Africa; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2018
Delamanid (Deltyba°) and multidrug-resistant pulmonary tuberculosis.
    Prescrire international, 2017, Volume: 26, Issue:181

    Topics: Antitubercular Agents; Electrocardiography; Humans; Long QT Syndrome; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2017
Journey of tuberculosis control in India.
    The Indian journal of tuberculosis, 2019, Volume: 66, Issue:1

    Topics: Antitubercular Agents; Diarylquinolines; Directly Observed Therapy; Goals; History, 20th Century; History, 21st Century; Humans; India; National Health Programs; Nitroimidazoles; Oxazoles; Practice Guidelines as Topic; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2019
Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of Tuberculosis.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Animals; Antitubercular Agents; Bacterial Load; Diarylquinolines; Disease Models, Animal; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Linezolid; Lung; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Nitroimidazoles; Organophosphates; Oxazoles; Oxazolidinones; Pyrazinamide; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary

2016
Reciprocity and Ethical Tuberculosis Treatment and Control.
    Journal of bioethical inquiry, 2016, Volume: 13, Issue:1

    Topics: Antitubercular Agents; Beneficence; Communicable Disease Control; Congresses as Topic; Diarylquinolines; Directly Observed Therapy; Ethical Analysis; Ethical Theory; Global Health; Humans; Moral Obligations; Nitroimidazoles; Oxazoles; Patient Isolation; Personal Autonomy; Pharmacovigilance; Poverty; Public Health; Social Justice; Social Responsibility; Tuberculosis, Laryngeal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Virtues

2016
Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany.
    BMC health services research, 2017, 03-08, Volume: 17, Issue:1

    Topics: Adult; Antitubercular Agents; Clinical Protocols; Clinical Trials as Topic; Cost-Benefit Analysis; Diarylquinolines; Drug Costs; Drug Therapy, Combination; Female; Germany; Humans; Linezolid; Male; Nitroimidazoles; Observational Studies as Topic; Oxazoles; Quality-Adjusted Life Years; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2017
Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis.
    European journal of immunology, 2006, Volume: 36, Issue:3

    Topics: Animals; Antineoplastic Agents; Bacterial Proteins; Bone Marrow Cells; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Helminthiasis; Interferon-gamma; Interleukin-4; Iron; Lung; Macrophage Activation; Macrophages; Matrix Metalloproteinase 12; Metalloendopeptidases; Mice; Mycobacterium tuberculosis; Oxazoles; Th1 Cells; Th2 Cells; Tuberculosis, Pulmonary

2006
[Recent progress in mycobacteriology].
    Kekkaku : [Tuberculosis], 2007, Volume: 82, Issue:10

    Topics: Animals; Antitubercular Agents; Bacterial Proteins; Bacteriology; DNA-Binding Proteins; Drug Design; Humans; Immunoenzyme Techniques; Japan; Mice; Minisatellite Repeats; Molecular Epidemiology; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Serologic Tests; Tuberculosis Vaccines; Tuberculosis, Pulmonary

2007
In vitro and in vivo activities of the nitroimidazole CGI 17341 against Mycobacterium tuberculosis.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:2

    Topics: Animals; Antitubercular Agents; Bacteroides fragilis; Culture Media; Drug Resistance, Microbial; Female; Hydrogen-Ion Concentration; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Tuberculosis, Pulmonary

1993
[Remote results of chemotherapy in tuberculosis].
    Problemy tuberkuleza, 1977, Issue:8

    Topics: Czechoslovakia; Ethambutol; Humans; Oxazoles; Phenylthiourea; Prothionamide; Rifampin; Thiosemicarbazones; Tuberculosis, Pulmonary

1977
[Effect of cycloserine and terizidon on intracellular reproduction of mycobacterium tuberculosis].
    Problemy tuberkuleza, 1975, Issue:1

    Topics: Animals; Antitubercular Agents; Culture Techniques; Cycloserine; Evaluation Studies as Topic; Guinea Pigs; Macrophages; Mycobacterium tuberculosis; Oxazoles; Tuberculosis, Pulmonary

1975
[Terisidon in chemotherapy of pulmonary tuberculosis].
    Problemy tuberkuleza, 1974, Issue:12

    Topics: Adult; Antitubercular Agents; Cycloserine; Drug Evaluation; Drug Tolerance; Female; Humans; Imines; Male; Oxazoles; Tuberculosis, Pulmonary

1974
[Preliminary note on Terizidone].
    Marseille medical, 1972, Volume: 109, Issue:11

    Topics: Adult; Antitubercular Agents; Female; Humans; Imines; Male; Middle Aged; Oxazoles; Tuberculosis, Pulmonary

1972
Pharmacokinetics of cycloserine and terizidone. A comparative study.
    Chemotherapy, 1974, Volume: 20, Issue:1

    Topics: Adolescent; Adult; Aged; Aldehydes; Cycloserine; Dose-Response Relationship, Drug; Half-Life; Humans; Imines; Kinetics; Male; Middle Aged; Oxazoles; Phthalic Acids; Schiff Bases; Time Factors; Tuberculosis, Pulmonary

1974
[Cycloserine and terizidone in the treatment of pulmonary tuberculosis: clinical study of tolerance].
    Revista brasileira de medicina, 1969, Volume: 26, Issue:2

    Topics: Cycloserine; Drug Tolerance; Female; Humans; Male; Oxazoles; Tuberculosis, Pulmonary

1969